TP53 and B-cell chronic lymphocytic leukemia: It is interesting to note that the results obtained in cell lines resemble those obtained in CLL primary cells pre-treated with CpG-ODN/IL15, suggesting that OSU and MEC-1 cell lines can be considered a good model to study the response of activated, not quiescent, CLL cells to p53-targeting molecules.